Related Experiment Video
Updated: Oct 29, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
CASK Silence Overcomes Sorafenib Resistance of Hepatocellular Carcinoma Through Activating Apoptosis and Autophagic
Bisha Ding1,2, Chang Bao2, Luqi Jin3
1Department of Breast Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Abstract:
Hepatocellular carcinoma (HCC) patients usually fail to be treated because of drug resistance, including sorafenib. In this study, the effects of CASK in HCC were investigated using gain- or loss-of-function strategies by performing cell counting kit-8 assay, colony formation assay, flow cytometry, transmission electron microscopy, immunofluorescent confocal laser microscopy, tumor xenograft experiment and immunohistochemistry staining. The current results suggested that CASK expression was positively associated with sorafenib resistance and poor prognosis of HCC. Moreover, inhibition of CASK increased the role of sorafenib partially by promoting apoptosis and autophagy, while CASK overexpression presented the opposite effects. Besides, when treatment with sorafenib, inhibition of apoptosis using the pan-caspase inhibitor Z-VAD-FMK and inhibition of autophagy using autophagy inhibitor 3-Methyladenine (3-MA) or small interfering RNA (siRNA) of LC3B all significantly reversed CASK knockout-induced effects, suggesting that both apoptosis and autophagy were involved in CASK-mediated above functions and autophagy played a pro-death role in this research. Intriguingly, similar results were observed in vivo. In molecular level, CASK knockout activated the c-Jun N-terminal kinase (JNK) pathway, and treatment with JNK inhibitor SP600125 or transiently transfected with siRNA targeting JNK significantly attenuated CASK knockout-mediated autophagic cell death. Collectively, all these results together indicated that CASK might be a promising biomarker and a potential therapeutic target for HCC patients.
Insights
Calcium/calmodulin-dependent serine protein kinase (CASK) promotes sorafenib resistance in hepatocellular carcinoma (HCC). Inhibiting CASK enhances sorafenib efficacy by promoting apoptosis and autophagy, suggesting CASK as a therapeutic target for HCC.
Area of Science:
- Oncology
- Molecular Biology
- Drug Resistance Research
Background:
- Hepatocellular carcinoma (HCC) treatment is often hindered by drug resistance, particularly to sorafenib.
- The role of Calcium/calmodulin-dependent serine protein kinase (CASK) in HCC progression and drug resistance remains largely unexplored.
Purpose of the Study:
- To investigate the functional role of CASK in hepatocellular carcinoma (HCC) and its association with sorafenib resistance.
- To elucidate the molecular mechanisms underlying CASK's influence on HCC cell death pathways and therapeutic response.
Main Methods:
- Utilized gain- and loss-of-function strategies to manipulate CASK expression in HCC cells.
- Employed cell counting kit-8 assay, colony formation assay, flow cytometry, transmission electron microscopy, immunofluorescence, xenograft experiments, and immunohistochemistry.
- Investigated the involvement of apoptosis and autophagy pathways, including the c-Jun N-terminal kinase (JNK) signaling.
Main Results:
- CASK expression positively correlated with sorafenib resistance and poor prognosis in HCC patients.
- CASK inhibition enhanced sorafenib efficacy by promoting apoptosis and autophagy, while CASK overexpression had opposite effects.
- Both apoptosis and autophagy were implicated in CASK-mediated effects, with autophagy playing a pro-death role, and CASK knockout activated the JNK pathway.
Conclusions:
- CASK plays a significant role in promoting sorafenib resistance and influencing cell death pathways in HCC.
- Targeting CASK, potentially through modulating apoptosis and autophagy via the JNK pathway, could overcome sorafenib resistance.
- CASK represents a promising biomarker and a potential therapeutic target for improving HCC patient outcomes.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
09:31Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
The Extrinsic Apoptotic Pathway
Inhibition of Cdk Activity
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Caspases
The Intrinsic Apoptotic Pathway